PubMed

Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.

Tobinick EL, Gross H.

J Neuroinflammation. 2008 Jan 9;5:2.PMID: 18184433 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.

Tobinick EL, Gross H.

BMC Neurol. 2008 Jul 21;8:27.PMID: 18644112 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Perispinal etanercept for treatment of Alzheimer's disease.

Tobinick E.

Curr Alzheimer Res. 2007 Dec;4(5):550-2. Review.PMID: 18220520 [PubMed - indexed for MEDLINE]Related citations

Perispinal etanercept for neuroinflammatory disorders.

Tobinick E.

Drug Discov Today. 2009 Feb;14(3-4):168-77. Epub 2008 Dec 6. Review.PMID: 19027875 [PubMed - indexed for MEDLINE]Related citations

Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.

Tobinick E.

Medscape J Med. 2008 Jun 10;10(6):135.PMID: 18679537 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Perispinal etanercept: potential as an Alzheimer therapeutic.

Griffin WS.

J Neuroinflammation. 2008 Jan 10;5:3.PMID: 18186919 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.

Tobinick E.

CNS Drugs. 2009 Sep 1;23(9):713-25. doi: 10.2165/11310810-000000000-00000. Review.PMID: 19689163 [PubMed - indexed for MEDLINE]Related citations

Perispinal etanercept: a new therapeutic paradigm in neurology.

Tobinick E.

Expert Rev Neurother. 2010 Jun;10(6):985-1002. Review. Erratum in: Expert Rev Neurother. 2010 Jul;10(7):1232. PMID: 20518613 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Perispinal TNF-alpha inhibition for discogenic pain.

Tobinick EL, Britschgi-Davoodifar S.

Swiss Med Wkly. 2003 Mar 22;133(11-12):170-7.PMID: 12715286 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study.

Tobinick E, Gross H, Weinberger A, Cohen H.

MedGenMed. 2006 Apr 26;8(2):25.PMID: 16926764 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Targeted etanercept for treatment-refractory pain due to bone metastasis: two case reports.

Tobinick EL.

Clin Ther. 2003 Aug;25(8):2279-88.PMID: 14512134 [PubMed - indexed for MEDLINE]Related citations

Editorial: cytokine inhibition for treatment of Alzheimer's disease.

Rosenberg PB.

MedGenMed. 2006 Apr 26;8(2):24. No abstract available. PMID: 16926763 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload.

Jobe LJ, Meléndez GC, Levick SP, Du Y, Brower GL, Janicki JS.

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1462-8. Epub 2009 Aug 7.PMID: 19666842 [PubMed - indexed for MEDLINE]Related citations

Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist.

Nash CL, Panaccione R, Sutherland LR, Meddings JB.

Can J Gastroenterol. 2001 Sep;15(9):607-11.PMID: 11573104 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.

Ollendorf DA, Klingman D, Hazard E, Ray S.

Clin Ther. 2009 Apr;31(4):825-35.PMID: 19446156 [PubMed - indexed for MEDLINE]Related citations

Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.

Handattu SP, Garber DW, Monroe CE, van Groen T, Kadish I, Nayyar G, Cao D, Palgunachari MN, Li L, Anantharamaiah GM.

Neurobiol Dis. 2009 Jun;34(3):525-34. Epub 2009 Apr 1.PMID: 19344763 [PubMed - indexed for MEDLINE]Related citations

Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.

Campanati A, Goteri G, Simonetti O, Ganzetti G, Giuliodori K, Giuliano A, Sabato S, Stramazzotti D, Gulini E, Dusi D, De Blasio S, Fabris G, Offidani A.

Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):371-7.PMID: 19505391 [PubMed - indexed for MEDLINE]Related citations

A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.

Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, Aqel B, Boardman L, Gores GJ, Harmsen WS, McClain CJ, Kamath PS, Shah VH.

Gastroenterology. 2008 Dec;135(6):1953-60. Epub 2008 Sep 13.PMID: 18848937 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept.

Mazzon E, Esposito E, Di Paola R, Muià C, Crisafulli C, Genovese T, Caminiti R, Meli R, Bramanti P, Cuzzocrea S.

Clin Exp Immunol. 2008 Jul;153(1):136-49. Epub 2008 May 26.PMID: 18505433 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept).

Yazisiz V, Avci AB, Erbasan F, Yildirim B, Terzioğlu E.

Colorectal Dis. 2008 Nov;10(9):953-4. Epub 2008 Feb 21.PMID: 18294265 [PubMed - indexed for MEDLINE]Related citations